Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03568552 · ClinicalTrials.gov registry record · NA
Patient Decision Aid for Opioid Use Disorder
A NA study of Opioid Use Disorder, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 7,554
- Enrollment target
- 1
- Study location
NCT03568552: Completed NA study of Opioid Use Disorder, sponsored by University of California, Los Angeles.
NCT03568552 is a NA study of Opioid Use Disorder that has completed, run by University of California, Los Angeles. The registered enrollment target is 7,554 participants, above the 4,627-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (63% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03568552, a NA study of Opioid Use Disorder, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,554 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the study is to test the effectiveness of the Patient Decision Aid for Opioid Use Disorder (PtDA-MAT) by conducting a stepped-wedge cluster-randomized trial in CA H\&SS (stratified by rural vs. non-rural areas) for adults with OUD. Patient outcomes will be tracked by (1) personal assessments (baseline, 3 months, and 6 months): drug use, overdose, healthcare utilization, and (2) clinical and administrative records (over approximately 24 months): drug treatment status and retention, physical and mental health diagnoses, arrest, incarceration, controlled substance use, and mortality. Multilevel models will be applied to test the intervention effects, controlling for possible temporal trends.
Primary Outcome
Treatment retention will be defined as time from initial treatment admission to either MAT discontinuation or most recent clinic visit followed by 2 months gap in treatment
Conditions Studied
Interventions
- BEHAVIORAL Patient Decision Aid
Study Locations (1)
California
- UCLA Integrated Substance Abuse Programs - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,554 participants |
| Start Date | 2020-08-03 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
What the finished NCT03568552 record still lists
NCT03568552 is an interventional study that assigns participants to a tested intervention. Its 7,554 participants enrollment target places it among the larger protocols in the corpus, above the 4,627-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (63% higher).
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Patient Decision Aid is the first listed.
NCT03568552 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03568552 about?
NCT03568552 is a clinical study titled "Patient Decision Aid for Opioid Use Disorder". The aim of the study is to test the effectiveness of the Patient Decision Aid for Opioid Use Disorder (PtDA-MAT) by conducting a stepped-wedge cluster-randomized trial in CA H\&SS (stratified by rural vs. non-rural areas) for adults with OUD. Patient outcomes will be tracked by (1) personal assessme...
What is the current status of trial NCT03568552?
This trial is currently completed. It is a NA study. The enrollment target is 7,554 participants. The study started on 2020-08-03. Estimated completion is 2024-08-31.
What conditions does trial NCT03568552 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT03568552?
The interventions under investigation include: Patient Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT03568552?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03568552 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03568552's enrollment target sits among peer trials
7,554 8th of 257 higher than 250 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03848312 · 7,600 participants · Phase 3
Preventing Alzheimer's With Cognitive Training
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
- NCT05199701 · 7,500 participants · NA
Prospective Case Collection Study for New Mammography Technologies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI